2B7K:XETRA:XETRA-iShares MSCI World SRI UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 12.036

Change

+0.09 (+0.77)%

Market Cap

USD 0.35B

Volume

0.25M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.26 (+0.50%)

USD 445.28B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.45%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.38 (+1.37%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.13 (+0.46%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.15 (+0.58%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.25 (+0.53%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+0.52 (+0.36%)

USD 98.84B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.25 (+0.48%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+1.72 (+1.64%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+1.86 (+0.30%)

USD 80.38B

ETFs Containing 2B7K:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.45% 46% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.45% 46% F 45% F
Trailing 12 Months  
Capital Gain 16.61% 67% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.61% 66% D+ 66% D+
Trailing 5 Years  
Capital Gain 76.53% 85% B 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.53% 84% B 82% B
Average Annual (5 Year Horizon)  
Capital Gain 14.34% 80% B- 77% C+
Dividend Return 14.34% 79% B- 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.85% 44% F 55% F
Risk Adjusted Return 103.59% 91% A- 92% A
Market Capitalization 0.35B 58% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.